Project Grant R35GM165442
- The National Institute of General Medical Sciences awarded the Regents of the University of Colorado–Denver $162,501 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop cross-disciplinary training in high-dimensional data analysis and communication for the next generation of biostatisticians and epidemiologists. The award funds a training program that equips trainees with analytical methods for handling complex biomarker data—including...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded The Regents of the University of Colorado, University of Colorado Colorado Springs $325,938 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The Klocko Laboratory will conduct fundamental research on genome organization and function in fungi, specifically examining how eukaryotic genomes are precisely organized...
- The National Institute of General Medical Sciences awarded The Regents Of The University Of Colorado, doing business as University Of Colorado-Denver, $296,757 under the Biomedical Research and Research Training program (CFDA 93.859) on July 10, 2026. The project investigates how tubulin and kinesin gene families specialize microtubule networks, addressing two critical knowledge gaps: the mechanistic role of tubulin isotypes in generating programs of tubulin post-translational modifications, and...
- The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded $2,053,480 to the University of Colorado-Denver beginning September 1, 2025, through August 31, 2029. This Project Grant funds the development of robust multivariate statistical methods for analyzing pathway interactions and pathway-phenotype associations in bulk and single-cell RNA sequencing (RNA-seq) studies. The research addresses critical reliability...
- The National Institute of General Medical Sciences awarded The Regents of The University of Colorado, doing business as University of Colorado-Denver, $429,000 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate chromatin landscape and DNA repair dynamics at dysfunctional telomeres. The research applies a multiscale approach integrating cell and molecular biology, chromatin biology, and single-molecule imaging to understand how...
- The National Institute of General Medical Sciences awarded the Regents Of The University Of Colorado, doing business as University Of Colorado-Denver, $429,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the regulation of bridge-like lipid transfer proteins (BLTPs). The research elucidates how BLTP function is regulated at endoplasmic reticulum (ER) and plasma membrane contact sites, with focus on the TWEEK complex and its role in...
- The National Institute of General Medical Sciences awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $494,703 for a Project Grant (R35GM161210) on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The recipient will conduct a five-year study examining the molecular regulation of transient cell polarity during cell division and migration. The work combines research in human cells, zebrafish models, and...
- The National Institute of General Medical Sciences, part of the National Institutes of Health under the Department of Health and Human Services, awarded The Regents of the University of Colorado $410,012 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the physiological and biomedical implications of chaos in fluid flow. The research combines computational and experimental methodologies to address two fundamental questions: how...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of Colorado-Denver a $1,998,288 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2029. The award funds investigator-initiated research to develop and apply Co-Translational Folding Tracking (COTFT), a novel technology platform designed to visualize and quantify protein co-translational folding...
- The National Institute of General Medical Sciences awarded $129,684 to The Regents of The University of Colorado (doing business as University of Colorado-Denver) on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to fund Project Grant K99GM166737. The award supports research into mechanisms of physiologic DNA damage in multiciliated cells. The research investigates how multiciliated cells that line the respiratory system, brain ventricles, and...
The National Institute of General Medical Sciences awarded The Regents Of The University Of Colorado (University of Colorado-Denver) $420,600 on August 26, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational frameworks that decode disease mechanisms through representation learning. The research addresses fragmented understanding of disease by creating interpretable data representations that integrate bulk and single-cell transcriptomic data across tissues, diseases, and technologies. The project pursues two primary directions: resolving cell-to-trait associations by building multimodal representations that automatically infer cell-type proportions and expression across thousands of bulk samples, and inferring missing expression data across multiple tissues and disease progression timepoints where ethical or practical constraints prevent complete tissue sampling. These computational models will enable inference of cell-type-specific changes, reconstruction of disease progression trajectories, and mechanistic insight into disease initiation, evolution, and divergence across individuals. Performance runs through April 30, 2031, with work performed in Aurora, Colorado. The award is structured as a Project Grant, the assistance type supporting investigator-initiated research under NIGMS' mission to advance fundamental scientific discoveries underlying human health and disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $420.6k | 8/26/26 |